Upload
jayson-thornton
View
219
Download
5
Embed Size (px)
Citation preview
Non-Surgical Periodontal Therapy Reduces
Coronary Heart Disease Risk Markers: A Randomized
Controlled TrialBokhari SAH, Khan AA, Butt AK, Azhar M,
Hanif M, Izhar M, Tatakis DNJournal of Clinical Periodontology 2012
Periodontal Disease is a chronic inflammatory and infectious disease
Systematic Reviews and Meta-analysis have provided evidence for an association of Periodontal disease and CHD and PD has been found to be associated with higher risk of CHD
Background
• PD also induces production of proinflammatory cytokines and acute-phase proteins. A positive association between CRP, fibrinogen levels, and peripheral leukocyte count with periodontitis has been documented by various studies
Background
This link of PD and Systemic Inflammatory markers is further strengthened by intervention studies where PT has shown reduction in inflammatory markers associated with CHD risk
Background
Investigate the effect of conventional, mechanical, non-surgical periodontal treatment on serum levels of hsCRP, fibrinogen and white blood cells in CHD patients with periodontitis.
Aim of study
Observe changes in clinical periodontal parameters of BOP, PPD, and CAL and Serum levels of hsCRP, Fibrinogen and WBCs following Periodontal therapy
Compare these changes to corresponding levels in periodontally untreated CHD patients
Determine the effect of PT on the reduction of CHD risk marker
Objectives of study
Study Design
A single-blind, parallel-arm, Randomized
Controlled Intervention Trial
Subjects
Angiographically confirmed CHD patients
with moderate to severe periodontitis
CHD was defined as having >50% stenosis of ≥1 coronary arteryOral /Periodontal Status was defined as ≥ 14 periodontally evaluable natural teeth > 20% of sites BOP+ ≥ 4 teeth with ≥ 1 site with PPD ≥ 4
mm and CAL ≥ 3 mm at same site
Exclusion Criteria
Diseases or conditions affecting or
potentially confounding
Periodontal status or systemic
Inflammatory Biomarker levels
Sample Size
Based on primary endpoint (serum CRP), Sample Size was calculated for 317 CHD patients with periodontitis to be randomized into intervention and control group at 2:1 ratio with 90% power to detect significant difference between groups.
Based on the observations of our pilot study
1. Reduction in BOP sites to ≤20%
2. Reduction in Sites with PPD ≥ 4 mm
by 50%
3. Reduction in Serum inflammatory
marker levels by 20%
Level of Achievement after Periodontal
Treatment
All CHD Subjects were on cardiac medications that includedAntiplatelets, betablockers, ARBs, ACE inhibitors, calcium channel antagonists, statins, diuretics and nitrates. Subjects were monitored for change in status of medications during follow-up visits
Cardiac medications
RESULTS
Based on 317 recruited subjects ITT Analysis was carried outA comparison of Intervention and Control groups at baseline revealed NO Significant Differences with respect to •Demographic and Medical parameters •Periodontal and systemic Inflammatory variables
Changes in Periodontal Parameters
E1, E2, E3 indicate 1st, 2nd , and 3rd Examination stages
a.
cb
a
****P>0.05
0
510
1520
25
3035
4045
50
E1 E2 E3
BO
P (
perc
en
tag
e)
Intervention group Control groupn=212 n=105
E1 and E3 indicate 1st and 3rd Examination Stages
Changes in Periodontal Parameters
b.
a
b
P>0.05
P>0.05
2.8
2.93
3.13.2
3.3
3.43.5
3.63.7
3.8
E1 E3
PP
D (
mm
)
Intervention group Control groupn=212 n=105
E1 and E3 indicate 1st and 3rd Examination Stages
Changes in Periodontal Parameters
c.
aa
P>0.05P>0.05
2.9
3
3.1
3.2
3.3
3.4
3.5
3.6
E1 E3
CA
L (
mm
)
Intervention group Control groupn=212 n=105
E1, E2 and E3 indicate 1st , 2nd and 3rd Examination Stages
Changes in Inflammatory Parameters
d.
a
b
c
***P>0.05
2.5
3
3.5
4
4.5
5
E1 E2 E3
CR
P (
mg
/L)
Intervention group Control groupn=212 n=105
E1, E2 and E3 indicate 1st , 2nd and 3rd Examination Stages
Changes in Inflammatory Parameters
e.
bb
a
*P>0.05
P>0.05
200
220240
260280
300
320340
360380
400
E1 E2 E3
FIB
(m
g/L
)
Intervention group Control groupn=212 n=105
E1, E2 and E3 indicate 1st , 2nd and 3rd Examination Stages
Changes in Inflammatory Parameters
f.
c
b
a
***P>0.05
5
5.5
6
6.5
7
7.5
8
8.5
E1 E2 E3
WB
C (
x109/L
)
Intervention group Control groupn=212 n=105
Effect of Periodontal Therapy on CRP ( > 3mg/L) based CHD Risk Category
ARR = 48.5%-36% = 12.5% (χ2=4.381, p=0.036)
Relative Risk Ratio = 1.34
Relative Risk Reduction= 26%Periodontal therapy may reduce high-risk CRP levels by 26% in CHD patients
NNT = 1 out of 8 CHD Patients with Moderate-Severe periodontitis may benefit from PT and lower serum CRP levels to mild risk(www.nottingham.ac.uk)
Conclusion
Treatment of periodontitis by conventional non-surgical periodontal therapy in CHD patients contributes to significant reduction in serum levels of systemic inflammatory markers associated with CHD Risk
• This reduction in systemic markers of CHD risk might lead to CHD risk reduction.
• Periodontal screening of CHD patients might help identify individuals who may benefit from periodontal therapy.
Conclusion
Evidence suggests an association of PD and CHD and CHD risk markers of CRP, Fibrinogen and WBCs are raised in patients with Periodontitis. Treatment studies provide conflicting results regarding the systemic effects of mechanical periodontal therapy. This trial lends further evidence to such researches.
Clinical Relevance/ Rationale of Study
In the absence of any change in systemic medication, mechanical periodontal therapy significantly reduces serum levels of C-reactive protein, fibrinogen and white blood cells in CHD patients
Principal Findings
Treatment of CHD patients with periodontitis using mechanical periodontal therapy can result in significant reduction of CHD risk markers
Practical Implications